Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Immunotherapy"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 222424

Starter badań:

Tytuł:
Treatment for food allergy: Current status and unmet needs.
Autorzy:
Dantzer JA; Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Md.
Kim EH; Division of Pediatric Allergy and Immunology and University of North Carolina Food Allergy Initiative, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
Chinthrajah RS; Department of Medicine, Sean N. Parker Center for Allergy and Asthma Research, and Department of Pediatrics, Stanford University, Stanford, Calif.
Wood RA; Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Md. Electronic address: .
Pokaż więcej
Źródło:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Jan; Vol. 151 (1), pp. 1-14. Date of Electronic Publication: 2022 Aug 23.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Food Hypersensitivity*/therapy
Sublingual Immunotherapy*/methods
Humans ; Allergens ; Desensitization, Immunologic/methods ; Food/adverse effects ; Immunotherapy
Czasopismo naukowe
Szczegóły
Tytuł:
The past, present, and future of immunotherapy for colorectal cancer.
Autorzy:
Formslag CR; Department of Microbiology, Immunology & Pathology, Des Moines University, Des Moines, IA, 50312, USA.
Zhao L; Department of Respiratory Medicine, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, AH, 230011, China.
Heslin AJ; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Lewis CC; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Miller CW; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Bai Q; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Wakefield MR; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.; Ellis Fischel Cancer Center, University of Missouri, Columbia, MO, 65212, USA.
Fang Y; Department of Microbiology, Immunology & Pathology, Des Moines University, Des Moines, IA, 50312, USA. .; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA. .; Ellis Fischel Cancer Center, University of Missouri, Columbia, MO, 65212, USA. .; Department of Microbiology, Des Moines University College of Osteopathic Medicine, Immunology & Pathology, Des Moines, IA, 50312, USA. .
Pokaż więcej
Źródło:
Medical oncology (Northwood, London, England) [Med Oncol] 2023 Feb 14; Vol. 40 (3), pp. 95. Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy*/methods
Colorectal Neoplasms*/pathology
Humans ; Immunotherapy, Adoptive/methods ; Cytokines ; Chemotherapy, Adjuvant
Czasopismo naukowe
Szczegóły
Tytuł:
Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer.
Autorzy:
Chen J; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
Hu J; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Gu L; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
Ji F; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
Zhang F; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
Zhang M; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
Li J; Nanjing Blue Shield Biotechnology Co., Ltd., Nanjing, 210023, China.
Chen Z; Nanjing Blue Shield Biotechnology Co., Ltd., Nanjing, 210023, China.
Jiang L; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Zhang Y; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Shi R; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Ma L; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Jia S; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Zhang Y; Department of Pathology, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Zhang Q; Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
Liang J; Inner Mongolia Autonomous Region Cancer Hospital, Hohhot, 010010, China.
Yao S; Baylor University, 1311 S 5th St, Waco, USA.
Hu Z; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China. huzg_.
Guo Z; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China. .
Pokaż więcej
Źródło:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Feb; Vol. 72 (2), pp. 409-425. Date of Electronic Publication: 2022 Aug 04.
Typ publikacji:
Journal Article
MeSH Terms:
Immunotherapy, Adoptive*
Ovarian Neoplasms*/therapy
Receptors, Chimeric Antigen*
Female ; Humans ; Cell Line, Tumor ; GPI-Linked Proteins ; Immunotherapy ; Animals
Czasopismo naukowe
Szczegóły
Tytuł:
The potential role of short chain fatty acids improving ex vivo T and CAR-T cell fitness and expansion for cancer immunotherapies.
Autorzy:
González-Brito A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
Uribe-Herranz M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Jan 20; Vol. 14, pp. 1083303. Date of Electronic Publication: 2023 Jan 20 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy, Adoptive*
Neoplasms*/therapy
Humans ; Immunotherapy ; T-Lymphocytes ; Fatty Acids, Volatile
Czasopismo naukowe
Szczegóły
Tytuł:
Recent progress in cancer immunotherapy: Overview of current status and challenges.
Autorzy:
Darvishi M; Infectious Diseases and Tropical Medicine Research Center (IDTMRC), Department of Aerospace and Subaquatic Medicine, AJA University of Medicinal Sciences, Tehran, Iran. Electronic address: .
Tosan F; Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran. Electronic address: .
Nakhaei P; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: .
Manjili DA; Department of Infectious Disease, School of Medicine, Babol University of Medical Sciences, Babol, Iran. Electronic address: .
Kharkouei SA; Department of Medicine, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: .
Alizadeh A; Department of Digital Health, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: .
Ilkhani S; Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: .
Khalafi F; Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: Farima_.
Zadeh FA; Department of Surgery, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: .
Shafagh SG; Faculty of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran. Electronic address: .
Pokaż więcej
Źródło:
Pathology, research and practice [Pathol Res Pract] 2023 Jan; Vol. 241, pp. 154241. Date of Electronic Publication: 2022 Nov 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy*
Neoplasms*/drug therapy
Humans ; Immunotherapy, Adoptive ; Antibodies, Monoclonal/therapeutic use ; Angiogenesis Inhibitors
Czasopismo naukowe
Szczegóły
Tytuł:
Cancer immunotherapy with CAR T cells: well-trodden paths and journey along lesser-known routes.
Autorzy:
Smole A; Immunology and Cellular Immunotherapy (ICI) Group, Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia.
Pokaż więcej
Źródło:
Radiology and oncology [Radiol Oncol] 2022 Dec 13; Vol. 56 (4), pp. 409-419. Date of Electronic Publication: 2022 Dec 13 (Print Publication: 2022).
Typ publikacji:
Review; Journal Article
MeSH Terms:
Immunotherapy*
Hematologic Neoplasms*
Humans ; Immunotherapy, Adoptive ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity.
Autorzy:
Vazquez-Lombardi R; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland; Engimmune Therapeutics AG, Hegenheimermattweg 167A, 4123 Allschwil, Switzerland. Electronic address: .
Jung JS; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
Schlatter FS; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
Mei A; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
Mantuano NR; Department of Biomedicine, Universitätsspital Basel, Basel, Switzerland.
Bieberich F; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
Hong KL; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
Kucharczyk J; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
Kapetanovic E; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
Aznauryan E; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
Weber CR; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
Zippelius A; Department of Biomedicine, Universitätsspital Basel, Basel, Switzerland.
Läubli H; Department of Biomedicine, Universitätsspital Basel, Basel, Switzerland.
Reddy ST; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland. Electronic address: .
Pokaż więcej
Źródło:
Immunity [Immunity] 2022 Oct 11; Vol. 55 (10), pp. 1953-1966.e10. Date of Electronic Publication: 2022 Sep 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy, Adoptive*
Receptors, Antigen, T-Cell*
Antigens, Neoplasm ; Humans ; Immunotherapy ; Peptides
Czasopismo naukowe
Szczegóły
Tytuł:
Correlation of serum vitamin D concentration with humoral-specific IgG2 and IgG4 levels in high responders to immunotherapy with a 300 IR sublingual house dust mite tablet.
Autorzy:
Fernandez JC; Stallergenes Greer, Antony, France.
Luce S; Stallergenes Greer, Antony, France.
Floch VB; Stallergenes Greer, Antony, France.
Canonica WG; Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Batard T; Stallergenes Greer, Antony, France.
Mascarell L; Stallergenes Greer, Antony, France.
Pokaż więcej
Źródło:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2022 Oct; Vol. 52 (10), pp. 1219-1224. Date of Electronic Publication: 2022 Jul 27.
Typ publikacji:
Letter
MeSH Terms:
Pyroglyphidae*
Sublingual Immunotherapy*
Animals ; Antigens, Dermatophagoides ; Dermatophagoides pteronyssinus ; Dust ; Humans ; Immunoglobulin G ; Immunotherapy ; Tablets ; Vitamin D
Opinia redakcyjna
Szczegóły
Tytuł:
Current updates on generations, approvals, and clinical trials of CAR T-cell therapy.
Autorzy:
Asmamaw Dejenie T; Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Tiruneh G/Medhin M; Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Dessie Terefe G; Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Tadele Admasu F; Department of Biochemistry, College of Medicine and Health Science Arbaminch University, Arbaminch, Ethiopia.
Wale Tesega W; Department of Biochemistry, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Chekol Abebe E; Department of Biochemistry, College of Medicine and Health Science Arbaminch University, Arbaminch, Ethiopia.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (6), pp. 2114254. Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:
Journal Article
MeSH Terms:
Immunotherapy, Adoptive*/methods
Neoplasms*
Humans ; Immunotherapy/methods ; Receptors, Antigen, T-Cell ; T-Lymphocytes ; Clinical Trials as Topic
Czasopismo naukowe
Szczegóły
Tytuł:
CAR T-cells for colorectal cancer immunotherapy: Ready to go?
Autorzy:
Ghazi B; Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.
El Ghanmi A; Mohammed VI International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.
Kandoussi S; Immuno-Genetics and Human Pathology Laboratory, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
Ghouzlani A; Immuno-Genetics and Human Pathology Laboratory, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
Badou A; Immuno-Genetics and Human Pathology Laboratory, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Nov 15; Vol. 13, pp. 978195. Date of Electronic Publication: 2022 Nov 15 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy*
Colorectal Neoplasms*/therapy
Humans ; Immunologic Factors ; Immunotherapy, Adoptive/adverse effects ; T-Lymphocytes ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Natural killer cells: the next wave in cancer immunotherapy.
Autorzy:
Chen X; Department of Biology, BeiGene (Beijing) Co., Ltd., Beijing, China.
Jiang L; Department of Biology, BeiGene (Beijing) Co., Ltd., Beijing, China.
Liu X; Department of Biology, BeiGene (Beijing) Co., Ltd., Beijing, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Jul 27; Vol. 13, pp. 954804. Date of Electronic Publication: 2022 Jul 27 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy*
Neoplasms*/therapy
Immunotherapy, Adoptive ; Killer Cells, Natural ; T-Lymphocytes
Czasopismo naukowe
Szczegóły
Tytuł:
Stem-like T cells and niches: Implications in human health and disease.
Autorzy:
Yi L; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.
Yang L; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Aug 17; Vol. 13, pp. 907172. Date of Electronic Publication: 2022 Aug 17 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Autoimmune Diseases*/therapy
Immunotherapy, Adoptive*
Humans ; Immunotherapy ; Stem Cells ; T-Lymphocytes
Czasopismo naukowe
Szczegóły
Tytuł:
A Commotion in the Skin: Developing Melanoma Immunotherapies.
Autorzy:
Brenner E; Department of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany.
Röcken M; Department of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany. Electronic address: .
Pokaż więcej
Źródło:
The Journal of investigative dermatology [J Invest Dermatol] 2022 Aug; Vol. 142 (8), pp. 2055-2060. Date of Electronic Publication: 2022 Mar 24.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy*/methods
Melanoma*/drug therapy
Antigens, Neoplasm ; Humans ; Immunotherapy, Adoptive ; T-Lymphocytes, Cytotoxic
Czasopismo naukowe
Szczegóły
Tytuł:
The Tmod cellular logic gate as a solution for tumor-selective immunotherapy.
Autorzy:
DiAndreth B; A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA. Electronic address: .
Hamburger AE; A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.
Xu H; A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA.
Kamb A; A2 Biotherapeutics, 30301 Agoura Rd., Agoura Hills, CA 91301, USA. Electronic address: .
Pokaż więcej
Źródło:
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2022 Aug; Vol. 241, pp. 109030. Date of Electronic Publication: 2022 May 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy*
Neoplasms*/therapy
Humans ; Immunotherapy, Adoptive
Czasopismo naukowe
Szczegóły
Tytuł:
Utilizing chemokines in cancer immunotherapy.
Autorzy:
Märkl F; Center for Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany; Member of the German Center for Lung Research (DZL), Munich, Germany.
Huynh D; Center for Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.
Endres S; Center for Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, Research Center for Environmental Health (HMGU), Neuherberg, Germany; German Center for Translational Cancer Research (DKTK), Munich, Germany.
Kobold S; Center for Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, Research Center for Environmental Health (HMGU), Neuherberg, Germany; German Center for Translational Cancer Research (DKTK), Munich, Germany. Electronic address: .
Pokaż więcej
Źródło:
Trends in cancer [Trends Cancer] 2022 Aug; Vol. 8 (8), pp. 670-682. Date of Electronic Publication: 2022 Apr 29.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy*
Neoplasms*/therapy
Chemokines/metabolism ; Humans ; Immunotherapy, Adoptive ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials.
Autorzy:
Stewart MD; Friends of Cancer Research. Electronic address: .
McCall B; Genentech, A Member of the Roche Group.
Pasquini M; Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research.
Yang AS; Xencor.
Britten CD; Amgen.
Chuk M; Food and Drug Administration.
De Claro RA; Food and Drug Administration.
George B; Food and Drug Administration.
Gormley N; Food and Drug Administration.
Horowitz MM; Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research.
Kowack E; Xencor.
McCoy C; Bristol Myers Squibb.
Morrow PK; Amgen.
Okoye E; Regeneron Pharmaceuticals.
Ricafort R; Bristol Myers Squibb.
Rossi J; CERo Therapeutics.
Sharon E; National Cancer Institute.
Theoret M; Food and Drug Administration.
Vegni F; Bristol Myers Squibb.
Yu T; Amgen.
Allen J; Friends of Cancer Research.
Pokaż więcej
Źródło:
Cytotherapy [Cytotherapy] 2022 Jul; Vol. 24 (7), pp. 742-749. Date of Electronic Publication: 2022 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Cytokine Release Syndrome*/etiology
Immunotherapy*/adverse effects
Neoplasms*/therapy
Antibodies, Bispecific ; Clinical Trials as Topic ; Humans ; Immunotherapy, Adoptive/adverse effects
Czasopismo naukowe
Szczegóły
Tytuł:
Gold-seaurchin based immunomodulator enabling photothermal intervention and αCD16 transfection to boost NK cell adoptive immunotherapy.
Autorzy:
Lin X; Key Laboratory of Biomedical Information Engineering of Ministry of Education, Institute of Biomedical Photonics and Sensing, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China; Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, China.
Li F; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China; School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Gu Q; Key Laboratory of Biomedical Information Engineering of Ministry of Education, Institute of Biomedical Photonics and Sensing, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
Wang X; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China; School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Zheng Y; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China; Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, China.
Li J; Key Laboratory of Biomedical Information Engineering of Ministry of Education, Institute of Biomedical Photonics and Sensing, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
Guan J; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China; College of Biological Science and Engineering, Fuzhou University, Fuzhou 350116, China.
Yao C; Key Laboratory of Biomedical Information Engineering of Ministry of Education, Institute of Biomedical Photonics and Sensing, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China. Electronic address: .
Liu X; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China; Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, China. Electronic address: .
Pokaż więcej
Źródło:
Acta biomaterialia [Acta Biomater] 2022 Jul 01; Vol. 146, pp. 406-420. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy, Adoptive*
Neoplasms*/pathology
Cytotoxicity, Immunologic ; Gold/metabolism ; Humans ; Immunologic Factors ; Immunotherapy ; Killer Cells, Natural ; Transfection ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer.
Autorzy:
Rahman MM; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.
Behl T; Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, India.
Islam MR; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.
Alam MN; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.
Islam MM; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.
Albarrati A; Rehabilitation Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.
Albratty M; Department of Pharmaceutical Chemsitry, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
Meraya AM; Practice Research Unit, Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan 45124, Saudi Arabia.
Bungau SG; Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.; Doctoral School of Biomedical Sciences, University of Oradea, 410073 Oradea, Romania.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Jun 13; Vol. 27 (12). Date of Electronic Publication: 2022 Jun 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Drug-Related Side Effects and Adverse Reactions*
Immunotherapy*/adverse effects
Immunotherapy*/methods
Neoplasms*/drug therapy
Cancer Vaccines/adverse effects ; Cancer Vaccines/therapeutic use ; Humans ; Immune Checkpoint Inhibitors/adverse effects ; Immune Checkpoint Inhibitors/therapeutic use ; Immunologic Factors/adverse effects ; Immunologic Factors/therapeutic use ; Immunotherapy, Adoptive/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Natural killer cell therapy: A new frontier for obesity-associated cancer.
Autorzy:
Mylod E; Cancer Immunology and Immunotherapy Group, Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin, 8, Ireland.
Lysaght J; Cancer Immunology and Immunotherapy Group, Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin, 8, Ireland.
Conroy MJ; Cancer Immunology and Immunotherapy Group, Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin, 8, Ireland; Cancer Immunology Research Group, Department of Physiology, School of Medicine, Trinity College Dublin, Dublin, 2, Ireland. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2022 Jun 01; Vol. 535, pp. 215620. Date of Electronic Publication: 2022 Mar 10.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy, Adoptive*
Neoplasms*/pathology
Cell- and Tissue-Based Therapy ; Humans ; Immunotherapy ; Killer Cells, Natural ; Obesity/complications ; Obesity/therapy
Czasopismo naukowe
Szczegóły
Tytuł:
What Inhibits Natural Killers' Performance in Tumour.
Autorzy:
Papak I; International Centre for Cancer Vaccine Science, University of Gdansk, Ul. Kładki 24, 80-822 Gdansk, Poland.
Chruściel E; International Centre for Cancer Vaccine Science, University of Gdansk, Ul. Kładki 24, 80-822 Gdansk, Poland.
Dziubek K; International Centre for Cancer Vaccine Science, University of Gdansk, Ul. Kładki 24, 80-822 Gdansk, Poland.
Kurkowiak M; International Centre for Cancer Vaccine Science, University of Gdansk, Ul. Kładki 24, 80-822 Gdansk, Poland.
Urban-Wójciuk Z; International Centre for Cancer Vaccine Science, University of Gdansk, Ul. Kładki 24, 80-822 Gdansk, Poland.
Marjański T; Department of Thoracic Surgery, Medical University of Gdansk, 80-210 Gdansk, Poland.
Rzyman W; Department of Thoracic Surgery, Medical University of Gdansk, 80-210 Gdansk, Poland.
Marek-Trzonkowska N; International Centre for Cancer Vaccine Science, University of Gdansk, Ul. Kładki 24, 80-822 Gdansk, Poland.; Laboratory of Immunoregulation and Cellular Therapies, Department of Family Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jun 24; Vol. 23 (13). Date of Electronic Publication: 2022 Jun 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy, Adoptive*/methods
Neoplasms*/therapy
Humans ; Immunotherapy ; Killer Cells, Natural ; T-Lymphocytes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 222424

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz